Immigration to the United States Essay Example | Topics and Well Written Essays - 500 words

Immigration to the United States - Essay Example There have been numerous arguments and ideas put forth, both, by the supporters and critics of immigration to the United States. One of the arguments put forth by those who feel that there need to be restrictions placed on immigrations, is that immigrations dilute the superior composition of the society. They feel that the infusion of heterogeneous groups dilutes the superiority of their countrymen. Earlier, the Americans did not face any problem, doing jobs that were not really meant for the higher strata of the society. However, with the natives of other countries coming in, these jobs have been allocated to them. The Americans, now, have grown increasingly partial in accepting these jobs. This, has, therefore, led to the classification of work. In addition to this, they feel that the immigrants were assets earlier on; and have now transformed into liabilities. It is commonly felt that the immigrant work force is now large and has pushed the Americans out of the work force employed. They also feel that the immigrants are a menace to American ideals. On the other hand, there are th

Earth's Lithosphere Essay Example | Topics and Well Written Essays - 1250 words

Earth's Lithosphere - Essay Example All these calamities are associated with changes in climatic conditions across the world. Scientists have not rested in imploring the cause and the solutions of these tragedies. For that case, this paper will discuss the concepts of greenhouse effect and global warming and their collective effects on the climate of the world. The paper will also pay specific focus to Wabash watershed and longitudinal effects of greenhouse and global warming on this surrounding. Introduction Greenhouse effect refers to a situation whereby temperatures of the earth increases due to reflection of terrestrial radiation by green gases found in the atmosphere. Global warming refers to the increase in earth’s temperature occasioned by the accumulated heat on the atmosphere of the earth. Greenhouse effect and global warning are interdependent considering that global warming occurs as a result of greenhouse effect. When the greenhouse gases reflect back terrestrial radiation on the atmosphere of the ea rth, the surface of the earth gets warmed more rapidly there increasing environmental temperature. Greenhouse effect in line with global warming has caused unrest among the scientists to the potential threats that are related tom the two environmental principles. Scientists have since discovered those long-term greenhouse effects will insurrect the temperatures of the earth thereby resulting to unfavorable climatic changes. In the views of Oxlade (2006), greenhouse effect is caused by the presence of particular natural green gases in the atmosphere of the earth. Scientists discoveries unveils that the presence of the natural green gases (carbon dioxide and water vapor) in the atmosphere is significant to the relative temperatures of the earth. The natural green gases are the ones that trap terrestrial radiation in mild form, which in turn maintains the temperatures of the earth. Absence of such gases in the atmosphere would result to low temperatures that would be insignificant to l ife of human beings and other organisms (Oxlade, 2006). However, the main bone of contention and center of controversies arises from the increase in volume of these gases in the atmosphere and the associated risks. Maslin (2007) ascertains that human activities since the beginning of industrial revolution have escalated the volume of the gases in the atmosphere, which in turn has resulted into global warming. According to Maslin (2007), human activities that involve burning of carbon fuels have tragically increased the concentration of carbon dioxide and other gases like nitrogen dioxide in the atmosphere. Maslin (2007) elucidates that accumulation of these gases in the atmosphere and their merger with atmospheric moisture has resulted into the formation of perceived partial blanket that reflects back long wave radiation from the surface of the earth. Excess accumulation of the greenhouse gases in the atmosphere has also contributed into depletion of the ozone layer that made of thr ee elements of oxygen gas responsible for the absorption of toxic solar radiation. Oxlade (2006) demonstrates that increased rate of deforestation has is one of the uncontrolled human activities that have led to increased levels of chlorofluorocarbons in the atmosphere. It is scientifically approved that trees and green vegetations found on the surface of earth play a critical in the absorption of carbon dioxide gases. Depletion of trees and natural vegetations will therefore lead to

Passive Ventilation of Modern and Traditional Malay Houses

Passive Ventilation of Modern and Traditional Malay Houses Comparing the Passive Ventilation Style of Modern Malay House in Belum Rainforest Resort With the Common Traditional Malay House in Malaysia. ABSTRACT The objectives of the research is to compare the passive ventilation style of Modern Malay  House in Belum Rainforest Resort with the common Traditional Malay House in Malaysia. The  research questions are what are the comparison of passive ventilation in Modern Malay House  in Belum with the common Traditional Malay House. Secondly. how does the orientation of  building affect the passive ventilation. Finally. How does the the passive ventilation system  works for Modern Malay House in Belum Rainforest Resort and Common Traditional Malay  House in Malaysia. These are the list of methodology that being used to help my research. Site  observation at Belum Rainforest Resort. internet research. articles and books. My analysis of  methodology is by studying and comparing the details of these two houses that are related to  the passive ventilation. The result is i found that Modern Malay House in Belum is lack of  details that contribute to passive ventilation system. Common Traditional Malay house is still  the best since it gives spotlight more on the passive ventilation. In a nutshell. house that focus  more on the passive ventilation are much better since it reduce the humidity and produces a  good thermal comfort in a building. In future. i hope that people will design buildings that  concentrate more on the passive ventilation rather than design. 1.0 INTRODUCTION What is Architecture ? The definition of Architecture is the art or practice of designing and  constructing buildings. Architects are the one who runs the world. They create an enjoyment  story in every building that they design so that the world would not be as boring as it is. When it  comes to architecture world it is super wide and it consist of many different styles and  techniques. Every country have their own styles of designing to express their country ‘s  uniqueness. One of the best design in the world is the building that meet the need and pretty  much response to the climate. Also. It needs to know about the microclimates and the climate  zone. know the basic physiology of human thermal comfort. reduce the loads and enhance  visual comfort by controlling the sun. Thermal mass are used to improved the comfort efficiency  and to pick a space-conditioning strategies that are climatic responsive. Vernacular architecture  is one of the architecture sty le that take seriously on all of this criteria when designing a building. Vernacular Architecture is being refer as a traditional buildings that are designed to meet  the local climate and culture. They design with using a deep understanding together with a  respect towards the nature. Vernacular architecture can be called as a sustainable architecture  as well since it are also built to sustain the environment without destroying it. Vernacular  architecture tends to evolve time after time to reflect the technological. reflect the historical  context in which it exist. reflect the cultural and also reflect the environment. This style of  architecture used the local resources and available energy and materials. so it can refer  accordingly to the climate. site and culture. The most common basic function in vernacular  architecture is to shield and protect from the weather conditions. Passive cooling system can not be separate from the vernacular architecture as they are  greatly related together. Passive cooling is a building design approach that targets on the heat  gain control and heat dissipation in a building in order to improve the indoor thermal comfort  with lower or zero energy usage. A good orientation of a building. proper design layout and  system used in a building will allow the passive ventilation system be in the building. Ventilation  is the main criteria in passive cooling system as it is the one that move the air from outside  building to the inside so that it can improve the thermal comfort of a building. And my case  study is to compare the passive ventilation of Modern Malay House in Belum Rainforest Resort ,  Perak with a common Traditional Malay House in Malaysia. 2.0 An Overview of the Modern Malay House in Belum Rainforest Resort. Perak. Malaysia As stated on Malaysia’s online website. Malaysia is a country that being classified as  a country that have a hot climate and humid tropical climate with all months above 18 degree  Celcius. Belum Rainforest Resort is the place which I picked for my case study. Belum  Rainforest Resort is located on the northern part of Malaysia and just below the boundary of the  other country which is Thailand. Belum Rainforest Resort is located in the middle of  jungle which is surrounded by the water element from the Lake of Banding or Tasik Banding. This make the place a great become as a great place for the passive cooling design. Extracted from http://lensahijau.blogspot.com/2012/10/the-establishment-of-air-house-standard_18.html The Malay House in Belum was design to be modern but yet still maintaining the basic  element of Traditional Malay House. The photo below is one of the Modern Malay House in  Belum Rainforest Resort. Extracted from http://www.maplandia.com/malaysia/perak/gerik/hotels/belum-rainforest-resort/ The similarity of this modern malay house with the traditional malay house in Malaysia is they  used completely 100 per cent wood as the main material for construction. 3.0– What are the Comparison of Passive Ventilation on the Modern Malay House in Belum Rainforest Resort with Common Traditional Malay House in Malaysia ? A traditional Malay House produce the ventilation by applying many of full length  windows and doors at the body level. ( Yuan, 1987: 76 ). Hassan and Ramli ( 2010 )  conclude that Huge openings on Malay house walls produce high air intakes outside to  lowering the performance of stack effect. The below diagram stated clearly that. most of the  outdoor and indoor temperatures were higher than 28 degree Celcius with the humidity level  in the house is higher than 60 per cent and the wind speed in Malay house flow in about 0.3  m / s to 3.4 m / s. Extracted from http://lensahijau.blogspot.com/2012/10/the-establishment-of-air-house- standard_18.html There are several comparison that can be found in Modern Malay House in Belum  Rainforest Resort. The Modern Malay House in Belum were design using a timber  construction. Most of the timber construction are not solid if to compare to a concrete  construction due to being build piece by piece. Since it is build piece by piece so it will  have a small gaps between a piece and a piece of wood. This small gaps is one of the  strategy in passive cooling system. The function of the small gaps is to allow the movement  of air into the house so that it could ventilate and automatically improve the indoor  environmental quality. Most of the traditional malay house have this thing but if to compare  to the modern side of malay house in Belum Rainforest Resort. it does not have this thing. It  does not have small gaps on the wall and floor. the small gaps only can be seen on the  outside of the house which is on the balcony’s floor. This is not good since it blocks t he air  from entering into the house. The unique thing about the Malay house is that it is built on  stilts. This approach in many ways has several benefits from a thermal, functional and safety  point of view. The raised floor, which is built higher than the ground, can catch winds of a  higher velocity ( Yuan. 1987 : 71 ). and the use of timber planks for the floor, which have  gaps between them, can bring the air into the inner space. The Balcony area that contain small gaps for air ventilation purpose. The inner side of the building which does not contain any floor gaps and wall gaps. Other than that. during my site observation I found that there is no ventilation through  roof joint that can be found in the house. This ventilation through roof joint also contribute  in Passive Cooling Design. It makes the house produce a large movement of air into the  building through the roof joint. Traditional Malay House really focus on the opening so that  they can have a good thermal comfort without producing energy that we do not need such as  electricity. Also. without opening through the roof joint the stack ventilation system will  obviously not happen. Extracted from http://lensahijau.blogspot.com/2012/10/the-establishment-of-air-house-standard_18.html How does the Passive   Ventilation   System Works for Modern Malay   house in Malaysia and Common  Traditional Malay House in   Malaysia ? Extracted from http://www.belumresort.com/acco_kampung_house.html The floor plan above shows the floor plan of the Modern Malay House in Belum Rainforest  Resort. Common Traditional Malay House Floor Plan Extracted from https://www.academia.edu/2377416/Chapter_2_Malaysian_Vernacular_Architecture_and_Its_Relationship_to_Climate Both Modern Malay House and Traditional Malay House are randomly arranged. This is  to ensure that the wind velocity in the houses in the latter path of the wind will not  substantially being reduced. Stack ventilation is the flow of air from outside which enter into the  building and goes out from the upper side of a the building. Stack ventilation use different  temperature to move the air. Hot air increases due to the lower pressure occur. It is sometimes  being called as a buoyancy ventilation. The below diagram shows how the stack ventilation  basically works. Extracted from http://sustainabilityworkshop.autodesk.com/buildings/stack-ventilation-and-bernoullis-principle Stack ventilation is one of the unique ventilation system that happen in a traditional malay  house. Based on my observation on the modern malay house in Belum Rainforest Resort. I  found that there is no stack ventilation happens on this house since there is no opening through  the roof joint for the air to go out. The other problem is this house does lifted up a bit by the  stilt but the other problem is that there is no floor gaps for the air to come in from below. This  modern malay house in Belum Rainforest Resort does not have the stack ventilation effect   compare to the original traditional malay house. The traditional malay house use the stack  ventilation effect to cool the inner side of the house. Stack ventilation makes the movement of  the air flow and enter from the opening on the downside and the side of the house. Then the air  slowly transfer to the upper side of the house and goes out through the openings on the roof  joint. Extracted from http://malay101.blogspot.com/2012/08/malay-architecture.html Even the modern malay house in Belum Rainforest Resort does not use the stack  ventilation system. they use the other system of ventilation which is the cross ventilation system  . Cross ventilation system is obtain when there is windows on the both sides of the room. This  caused the air to flow across the space. Since the wind comes the most on the side of the  building. Openings on the sideway really helps the modern malay house in Belum Rainforest  Resort to give a better thermal comfort. The cross ventilation system is good since it reducing  the energy consumption in a building. The below diagram shows the cross ventilation system  that happens on modern malay house in Belum Rainforest Resort. The arrows on the diagram above shows the air movement that flows into the house. Other than that ,the unplanned arrangement of the Traditional Malay House is really  important as it gives contribution in reducing the risk of the strong winds. ( Hanafi. 1994 ). Settlements that are along the coastal areas experience great wind speed than the inland  religions. ( Hanafi. 1994 ) Traditional Malay House are usually detached and it dispersed the  units with ample external space. This is to allow the fresh air circulation occurs in the building. (Hanafi. 1994 ). Extracted from https://www.academia.edu/2377416/Chapter_2_Malaysian_Vernacular_Architecture_and_Its_Relationship_to_Climate Extracted from https://www.google.com.my/maps/@5.5428286,101.341145,187m/data=!3m1!1e3 Photo above is the rough arrangement of modern malay house in Belum Rainforest  Resort. The arrangement are based on the linear concept and which it is applying the same  concept as the traditional malay house in Malaysia. How does the orientation of the  building affect the passive  ventilation? Building orientation are really important in malay traditional house. For religious  reasons. most traditional Malay houses are oriented to face Mecca(east west direction) ,  which indirectly minimizes the area of exposed walls to direct solar radiation during theday  (Yuan. 2011). The building orientation also does help in providing good sun shading. and  also a good ventilation system. Normally. the Malay Kampong House will be orientate  according to the east – west orientation. This orientation function as letting you to harness  the daylight and take control of the glare along the long faà §ade of the building. It will reduce  the glare from the setting sun or even from the rising sun. One more reason on why east –  west orientation is the best orientation is because of it ensures the building to get a better  thermal comfort. The photo below show that the not so accurate wind diagram that being  taken from the windfinder.com. Extracted from http://www.windfinder.com/windstatistics/butterworth Based on my research study I found that most of the wind comes from the Northwest and  Northeast side. There is least air comes from the northern and the southern side. This  orientation system works pretty well since the modern malay house in Belum Rainforest Resort  are orientated using the east west orientation. The window on the modern malay house in  Belum Rainforest Resort that located on the side of the house is openable so this can make the  wind to flow into the building and circulate in good way. The below photo shows the orientation  of the modern malay house in Belum Rainforest Resort. Extracted from https://www.google.com.my/maps/@5.5428286,101.341145,187m/data=!3m1!1e3 Building that are surrounded by the water element are good for passive cooling design. What I found is Belum Rainforest Resort is surrounded by a big lake which is the Tasik Banding  . This Tasik banding contribute pretty well in making the house cooler and achieve the correct  standard of thermal comfort. The wind which flow from the Northwest side brings the cool air  from the lake and directly enter the building. – Conclusion In a nutshell. Malaysia is a country that are meant to be as a hot climate  country with a high humidity level. Houses in Malaysia that will be design or already  been designed by people need to follow the Malaysia ‘ s climate to achieve a good  thermal comfort. Modern Malay House in Belum Rainforest Resort are lack of the  original features that suppose to have in every Traditional Malay House. People that  design the malay house in Belum are not concentrating on the features anymore. in  fact they are more in terms of creating a new building with using a different way to  achieve the thermal comfort. The house might look like a malay traditional house  when you look it from the farthest distance. but it is totally different when you come  closer and study about the details of the house. Modern Malay House in Belum are  lack in terms of passive ventilation contribution. The house pretty much does not  apply the basic elements of a traditional malay house which is to have the wall gaps  and small gaps between the timber for the air to move into the building. This is such  a waste since this small features is actually really make the building to achieve a very  good environmental indoor quality. The ventilation through the roof joint also is a  good thing when it comes to express the stack ventilation system. Since traditional  malay house don’t use the electricity more often than a normal building. this stack  ventilation really works in every traditional malay house because it reduce the energy  consumption and automatically reduce the living cost. Also. stack ventilation  makes the traditional malay house to get a maximum ventilation from almost every  side of the house which the wind are basically come from the bottom. middle and  even from the upper side of the house. Other than that. the layout arrangement in  malay house will contribute in making the place become more comfortable. Layout  arrangem ent is one of the criteria in vernacular architecture. this layout arrangement  will contribute on the flow of the wind. Last but not least it is important as well to  orientate the building in a proper direction. The proper building orientation will make  the building to receive a good sun shading device. better air ventilation system so  that the building would not be hotter on the inside.

Two Scavengers in a Truck,Two Beautiful People in Mercedes and Nothings

Two Scavengers in a Truck,Two Beautiful People in Mercedes and Nothings Changed Compare and contrast of two poems from different cultures- ‘Two Scavengers in a Truck, Two beautiful People in Mercedes’ and ‘Nothings Changed’. ‘Two Scavengers in a Truck, Two Beautiful People in Mercedes’ by Lawrence Ferlinghetti, is a poem about four very different people brought together by traffic lights turning red. The poet is protesting against the inequalities within a democracy. ‘Nothings Changed’ by Tatamkhulu Afrika, is a poem which is also protesting, but about the way black people are treated in a place where the poet used to live, in District Six, in South Africa, where apartheid took place. In the poem ‘Two Scavengers in a Truck, Two Beautiful People in Mercedes’, the poet compares four people. The four people are brought together by the traffic light turning red. The poem is set in downtown San Francisco at 9 O’clock in the morning. First he describes the two garbage men in their truck. He compares them with a very elegant couple in their Mercedes, who have a very different lifestyle. The poet describes the two garbage men as- ‘two scavengers up since four a.m. grungy from their route’ This phrase creates the image of vultures swooping around San Francisco early while everyone is asleep, because vultures are often described as scavengers. The word ‘grungy’ also makes it clear to the reader that the garbage men are dirty and grubby. The writer tells us that the garbage men have been up since four a.m. This tells us that they are hard workers. In contrast, the poet describes the couple in the Mercedes as- ‘The man in a hip three piece linen suit with shoulder length blond hair and sun... ...manner, and the writer clearly wants to make himself heard. The poet, Tatamkhulu Afrika also talks about his own personal experiences, but on the other hand Lawrence Ferlinghetti, just writes about people he might have seen on the street. I personally preferred ‘Nothings Changed’ by Tatamkhulu Afrika, although I really liked ‘Two Scavengers in a Truck, Two Beautiful People in Mercedes’ by Lawrence Ferlinghetti, I thought ‘Nothings Changed’ was more thought provoking and I think I learnt more about the poet from it, because he was not afraid to express his feelings and opinions. However, I agree with both of the poets on their opinions. I think that everyone should be treated equally and no one should be made to feel like they are worse than someone else, just because they do not have a sophisticated car or because they are a different race or colour.

A Global Overview of a Fast Relief Market

A Project Report On A Global Overview Of A FAST RELIEF Market Submitted in Partial fulfillment for the requirement of the Degree of Master of Business Administration (International Business) from SUS College of engineering and technology,Tangori, Mohali.. Under the Guidance of: Submitted to: Mr. SUNIL Mr. ANIL Mr. PANKAJ SIR Submitted By: NANCY GOYAL MBA Acknowledgement I am very much thankful to Mr. Karun Narang (MD, Eastern Medikit Ltd. ) and Mr. D.Tyagi (AGM, Eastern Medikit Ltd) who allowed me to undergo summer training in their esteemed organization. This report deserves the special mention of few names, Mr. SUNIL PALand Mr. ANIL KUMAR SINGH , who guided me all the way and helped me at each of the stage. They helped me to gain knowledge about the various aspects of their organization. They shared their professional experiences, which will be very much useful for me in the long run. I would like to give a bunch of thanks to Mr. Bhupendra Singh, Mr. Krishna Sharma, Mr. V. P. Joshi , Mr. Jagmohan Roy, Mr. Pankaj Pandey, Mr. Amit Sharma, Mr. Guru Prasad, Mr. Pradeep Dua, Mr.Kunjal Patel, Mr. Ajay Sharma, Miss Piyali Chakraborty and Mr. Ankkur who helped me to improve my research work. I can not forget to thank all those people who directly or indirectly cooperated me during my training period. NANCY GOYAL SUS C. E. T TANGORI MOHALI.. INDEX * Introduction What is Fast Relief Medikit’s fast relief Details Competitors and Their Profile * SWOT Analysis PEST Analysis * Competitive analysis * Marketing mix * Strategies * Costs * Media costs Eastern Medikit Ltd Medikit is the India’s largest medical device export company Medikit has 5 manufacturing facilities in and around Gurgaon, covering 125,000 sq. ft with 25,000 sq. ft as class 10,000 and class 1,00,000 clean rooms. Our organizational strengths are rooted within Medikit's unique flexibility to evolve and improve products and processes by deployment of globally competent manufacturing practices. Read Chapter 8 Microbial GeneticsWith ongoing in-house development of proprietary equipment and manufacturing techniques, our research and development activities along with our exclusive design and development centre ensure that Medikit is customer-driven and stays ahead, always. FAST RELIEF Definition â€Å"Fast relief† is a pain reliever product of medikit ltd. It is a extra strong pain reliever product. The main competitors of this is MOOV and HIMANI FAST RELIEF.. The new launched product fast relief has a unique and ayurvedic composition elements.. like Oil of wintergreen 15. 0%Pudina ka phool 5% Tarpin tel 3% Nilgiri tel 2% Base (bees wax) q. s. All these ingredients provides ‘sootthing warmth’ to relieve pain instantly.. which is the requirement. Purpose The purpose of this product is basically to give relief instantly from the backache pain. It works with its special ingredients to give relief from the backache. Its main purpose is to give warmth and soothi ng feeling at the pain area and to give quick relief.It works like a miracle at the pain.. Company’s Product Details MedifinTM| |   FAST RELIEF from MEDIKIT | | | Geographic Markets:DELHI , UP, MUMBAI, VARANASI, CHENNAI, BANGLORE, CHANDIGARH, LUCKNOW.. | | Product Details | Benefits| Being in topical form it is devoid of all undesireable effects of oral route.. | So it helps to maintain the valid effects. | Soft and therapeutic. | Gives instant relief. | Starts work immediately after application. | Complies with standard and quality norms. | Attractive design and coloured packaging. | Gives satisfaction quickly.. Gives soothing warmth. | To improve the body muscles so that relive remains for more time. | No sideeffects . | An ayurvedic cure. | Topical preparation gives therapeutic effects only at the site of application that’s local relief.. | Cheap and economical. Specially for common man. | MARKETING OF THE PRODUCT.. INTRODUCTION.. MARKETING IS ONE OF THE IMPORTANT ASPECT OF ANY BUSINESS AND SO WE WOULD ANALYSE VARIOUS MARKETING STRATEGIES MAINLY PEST ANALYSIS AND SWOT ANALYSIS , COMPETITIVE ANALYSIS ARE BEEN DONE AND EXPLAINED IN THERE..MARKET SEGMENTATION AND TARGETING.. DELHI,UP,MUMBAI, VARANASI,BRALIEY,CHENNAI,BANGLORE, CHANDIGARH,LUCKNOW,MP,CALCUTTA. AGE- ABOVE 30 YEARS. GENDER- SPECIALLY FOR FEMALES. FAMILY SIZE- FOR BOTH BIG AND NUCLEAR FAMILIES SOCIO ECO CLASS- MIDDLE AND LOWER MIDDLE CLASS. PEST ANALYSIS.. Pest analysis stands for political,economical,social,and,technological analysis of macroenviornmental factors used in the environmental scanning component of strategic management. it is a part of the external analysis when onducting a strategic analysis or doing market research and gives a certain overview of the different macroenviornmental factors that the company has to take into the consideration. It is a useful strategic tool for understanding market growth or decline, business position, potential,and direction for operations. . POLITICAL- Govt support. , no risk for OTC brands. ECONOMIC- It is cheap and economical.. as it is available in different-different small packaging. It enhances the GDP growth and liberlisation.SOCIAL- Its is a innovative product suits the demands of the changing preferences of the society. It is suitable for the needs and aspirations of the common individual. TECHNOLOGICAL- It is made by the use of best technological machines. It has given a quality packaging with double lamination on the outer and inner area of the tube. SWOT ANALYSIS. Swot analysis is a strategic planning method used to evaluate the strengths, weaknesses, opportunities and threats involved in a project or in a business venture..STRENGTHS- It is an ayurvedic product. It is quick and instant pain reliever than any other relief balm. Its branding is fabulous and standardized Its channels of distribution and dedicated Employees working for its successful promotion. A huge capital investment.. WEAKNESS- It is a new product in the market. It has low market share now. OPPORTUNITIES- There is a huge market demanding innovation And change.Changing tastes and preferences of consumers. THREATS- The problem of brand loyality and mindset of Consumres regarding a specific product and its Quality. Popularity of competitive brands like moov. The condition of market is also a big threat. . POSITIONING STRATEGY.. The positioning strategy is an effective and important instrument for a business venture and for the product as well. As it causes the success of the product.. â€Å"FAST RELIEF† â€Å"AN AYURVEDIC CURE FOR YOUR PAIN†The positioning strategy should be strong and effective enough to make the product strong and popular.. TARGET AUDIENCE The main target audience are middle class family and low midlle class family woman, who works in the offices as well as in homes and have no time to go to doctors for their ignorable backaches.. INDUSTRY PROFILE Industry Definition â€Å"The Indian pha rmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent. † Richard GersterThe Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4. 5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously.Playing a key role in promoting and sustaining development in the vital field of medicines, Indian Pharma Industry boasts of quality producers and many units approved by regulatory authorities in USA and U K. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world. The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades.The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectibles. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units).These units produce the complete range of pharmaceutical f ormulations, i. e. , medicines ready for consumption by patients and about 350 bulk drugs, i. e. , chemicals having therapeutic value and used for production of pharmaceutical formulations. Following the de-licensing of the pharmaceutical industry, industrial licensing for most of the drugs and pharmaceutical products has been done away with. Manufacturers are free to produce any drug duly approved by the Drug Control Authority.Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on the international market. ADVANTAGE IN INDIA Competent workforce: India has a pool of personnel with high managerial and technical competence as also skilled workforce. It has an educated work force and English is commonly used. Professional services are easily available. Cost-effective chemical synthesis: Its track record of development, particularly in the area of improved cost-beneficial chemical synthesis for various drug molecules is excellent. It provides a wide variety of bulk drugs and exports sophisticated bulk drugs. Legal & Financial Framework: India has a 53 year old democracy and hence has a solid legal framework and strong financial markets. There is already an established international industry and business community.Information & Technology: It has a good network of world-class educational institutions and established strengths in Information Technology. Globalization: The country is committed to a free market economy and globalization. Above all, it has a 70 million middle class market, which is continuously growing. Consolidation: For the first time in many years, the international pharmaceutical industry is finding great opportun ities in India. The process of consolidation, which has become a generalized phenomenon in the world pharmaceutical industry, has started taking place in India.THE GROWTH SCENARIO India's US$ 3. 1 billion pharmaceutical industry is growing at the rate of 14 percent per year. It is one of the largest and most advanced among the developing countries. Over 20,000 registered pharmaceutical manufacturers exist in the country. The domestic pharmaceuticals industry output is expected to exceed Rs260 billion in the financial year 2002, which accounts for merely 1. 3% of the global pharmaceutical sector. Of this, bulk drugs will account for Rs 54 bn (21%) and formulations, the remaining Rs 210 bn (79%).In financial year 2001, imports were Rs 20 bn while exports were Rs87 bn. The above graph shows the percentage of pharmaceutical products export by various countries. (SOURCE Competitiveness of the Indian pharmaceutical industry in the new product patent regime a report by FICCI) RESEARCH AND DEVELOPMENT Drug discovery is the process by which potential drugs are discovered or designed. In the past most drugs have been discovered either by isolating the active ingredient from traditional remedies or by serendipitous discovery.Modern biotechnology often focuses on understanding the metabolic pathways related to a disease state or pathogen, and manipulating these pathways using molecular biology or Biochemistry. A great deal of early-stage drug discovery has traditionally been carried out by universities and research institutions. Drug development refers to activities undertaken after a compound is identified as a potential drug in order to establish its suitability as a medication. Objectives of drug development are to determine appropriate Formulation and Dosing, as well as to establish safety.Research in these areas generally includes a combination of in vitro studies, in vivo studies, and clinical trials. The amount of capital required for late stage development has mad e it a historical strength of the larger pharmaceutical companies Often, large multinational corporations exhibit vertical integration, participating in a broad range of drug discovery and development, manufacturing and quality control, marketing, sales, and distribution. Smaller organizations, on the other hand, often focus on a specific aspect such as discovering drug candidates or developing formulations.Often, collaborative agreements between research organizations and large pharmaceutical companies are to explore the potential of new drug substances formed The cost of innovation Drug discovery and development is very expensive; of all compounds investigated for use in humans only a small fraction are eventually approved in most nations by government appointed medical institutions or boards, who have to approve new drugs before they can be marketed in those countries.Each year, only about 25 truly novel drugs (New chemical entities) are approved for marketing. This approval come s only after heavy investment in pre-clinical development and clinical trials, as well as a commitment to ongoing safety monitoring. Drugs which fail part-way through this process often incur large costs, while generating no revenue in return. If the cost of these failed drugs is taken into account, the cost of developing a successful new drug (New chemical entity or NCE), has been estimated at about 1 billion USD.A study by the consulting firm Bain ; Company reported that the cost for discovering, developing and launching (which factored in marketing and other business expenses) a new drug (along with the prospective drugs that fail) rose over a five year period to nearly $1. 7 billion in 2003. These estimates also take into account the opportunity cost of investing capital many years before revenues are realized (see Time-value of money). Because of the very long time needed for discovery, development, and approval of pharmaceuticals, these costs can accumulate to nearly half the total expense.Some approved drugs, such as those based on re-formulation of an existing active ingredient (also referred to as Line-extensions) are much less expensive to develop. The consumer advocacy group Public Citizen suggests on its web site that the actual cost is under $200 million, about 29% of which is spent on FDA-required clinical trials. For me-too-drugs and for generics, the cost are even less. Calculations and claims in this area are controversial because of the implications for regulation and subsidization of the industry through federally funded research grants.Controversy about drug development and testing There have been increasing accusations and findings that clinical trials conducted or funded by pharmaceutical companies are much more likely to report positive results for the preferred medication. In response to public outcry about specific cases in which unfavorable data from pharmaceutical company-sponsored research was suppressed, the Pharmaceutical Research and Manufacturers of America have published new guidelines urging companies to report all findings and limit the financial involvement in drug companies of researchers.As a result of this public outcry and Pharma response the US congress signed into law a bill which requires phase II and phase III clinical trials to be registered by the sponsor on the NIH website Drug researchers not directly employed by pharmaceutical companies often look to companies for grants, and companies often look to researchers for studies that will make their products look favorable. Sponsored researchers are rewarded by drug companies, for example with support for their conference/symposium costs.Lecture scripts and even journal articles presented by academic researchers may actually be ‘ghost-written' by pharmaceutical companies. Some researchers who have tried to reveal ethical issues with clinical trials or who tried to publish papers that show harmful effects of new drugs or cheaper alternative s have been threatened by drug companies with lawsuits. Product approval in the US In the United States, new pharmaceutical products must be approved by the FDA as being both safe and effective.This process generally involves submission of an Investigational new drug filing with sufficient pre-clinical data to support proceeding with human trials. Following IND approval, three phases of progressively larger human clinical trials may be conducted. Phase I generally studies toxicity using healthy volunteers. Phase II can include Pharmacokinetics and Dosing in patients, and Phase III is a very large study of efficacy in the intended patient population. A fourth phase of post-approval surveillance is also often required due to the fact that even the largest clinical trials cannot effectively predict the prevalence of rare side-effects.Post-marketing surveillance ensures that after marketing the safety of a drug is monitored closely. In certain instances, its indication may need to be li mited to particular patient groups, and in others the substance is withdrawn from the market completely. Questions continue to be raised regarding the standard of both the initial approval process, and subsequent changes to product labeling (it may take many months for a change identified in post-approval surveillance to be reflected in product labeling) and this is an area where congress is active. The FDA provides information about approved drugs at the Orange Book site. In the UK, the British National Formulary is the core guide for pharmacists and clinicians. Orphan drugs There are special rules for certain rare diseases (â€Å"orphan diseases†) involving fewer than 200,000 patients in the United States, or larger populations in certain circumstances. Because medical research and development of drugs to treat such diseases is financially disadvantageous, companies that do so are rewarded with tax reductions, fee waivers, and market exclusivity on that drug for a limited t ime (seven years), regardless of whether the drug is protected by patents.Industry revenues For the first time ever, in 2006, global spending on prescription drugs topped $643 billion, even as growth slowed somewhat in Europe and North America. The United States accounts for almost half of the global pharmaceutical market, with $289 billion in annual sales followed by the EU and Japan. Emerging markets such as China, Russia, South Korea and Mexico outpaced that market, growing a huge 81 percent. US profit growth was maintained even whilst other top industries saw slowed or no growth. Despite this, â€Å".. he pharmaceutical industry is — and has been for years — the most profitable of all businesses in the U. S. In the annual Fortune 500 survey, the pharmaceutical industry topped the list of the most profitable industries, with a return of 17% on revenue. † Pfizer's cholesterol pill Lipitor remains the best-selling drug in the world for the fifth year in a row. Its annual sales were $12. 9 billion, more than twice as much as its closest competitors: Plavix, the blood thinner from Bristol-Myers Squibb and Sanofi-Aventis; Nexium, the heartburn pill from AstraZeneca; and Advair, the asthma inhaler from GlaxoSmithKline.IMS Health publishes an analysis of trends expected in the pharmaceutical industry in 2007, including increasing profits in most sectors despite loss of some patents, and new ‘blockbuster' drugs on the horizon. Teradata Magazine predicted that by 2007, $40 billion in U. S. sales could be lost at the top 10 pharma companies as a result of slowdown in R&D innovation and the expiry of patents on major products, with 19 blockbuster drugs losing patent. STEPS TO STRENGTHEN THE INDUSTRY Indian companies need to attain the right product-mix for sustained future growth.Core competencies will play an important role in determining the future of many Indian pharmaceutical companies in the post product-patent regime after 2005. Indian companies, in an effort to consolidate their position, will have to increasingly look at merger and acquisition options of either companies or products. This would help them to offset loss of new product options, improve their R&D efforts and improve distribution to penetrate markets. Research and development has always taken the back seat amongst Indian pharmaceutical companies.In order to stay competitive in the future, Indian companies will have to refocus and invest heavily in R&D. The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. INTRODUCTION TO EASTERN MEDIKIT LTDCOMPANY PROFILE â€Å"A company empowered by one mission †“to place itself on the world map. An enterprise propelled by one force-that synergizes its energies to charter unexplored markets. Organizations fuelled by one dream-to transform competition into opportunity. † Eastern Medikit Ltd Laboratories Ltd. was incorporated in June 1961, in the name of M/S LEPITIT EASTERN MEDIKIT LTD LABORATORIES LTD and it commenced its business in MARCH 1962, in technical and financial collaboration with an international company named LEPTIT SPA, MILAN, ITALY.Eastern Medikit Ltd Laboratories Pvt. Ltd. merged with â€Å"Leptit Eastern Medikit Ltd Laboratories Pvt. Ltd. † in 1962 Eastern Medikit Ltd and company also merged with this company in 1966. The collaboration arrangement with M/S LEPTIT was terminated in 1966; after which Indian nationals acquired the entire share capital of the company. Therefore the word Leptit was removed from the name of the company. The name is known as EASTERN MEDIKIT LTD LABORATORIES LIMITED. In 1973 the compan y issued shares to the general public and became a full fledged PUBLIC LIMITED COMPANY.Today, Eastern Medikit Ltd has emerged as a Leading Pharmaceutical Company on the Indian firmament, with the second largest market share and enjoys an enviable reputation for its high standard of ethics and quality around its core strength of anti-infective, it has produced new brands in emerging therapeutic areas like cardiovascular, central nervous system and nutritional. supporting this expansion, the company has invested in world class manufacturing infrastructure that leverages India’s comparative cost advantage and skilled manpower, while delivering international quality.The company’s drive for Internationalism is guided by the well planned brand strategy that covers some of the world emerging markets like China, cis, Central Europe and Latin America . Its position today is in league of the Top Ten Pharmaceutical companies of three world an decent ranking as the eleventh larges t company in the international generics space is the resounding endorsement of its strategic mind. It is clear that for a long time, the dominant share of revenues of the company would continue to come from the ever expanding global generics market.Hence the intent of Eastern Medikit Ltd mission is to achieve a sustained growth rate through the continuous pursuit of innovation phase one trials for pervasion, a compound for treating prosthetic males have been completed. Phase 1 trials with clafrinast, an asthma compound is an important step towards research based value creation. This company also had success with Ciplofloxacine, an ingenious form, created through the novel drug delivery systems research.As the demand of the bulk drugs inside the country and abroad was increasingly rapidly a new, plant was set up at Toansa near Ropar in 1987. This was a higher capacity plant designed to cater to the present and future needs, initially antibiotics like Ampicillin, Trihydrate and Doxycy cline were manufactured. Later, on the other drugs like Cephalexin monohydrate and Ranitidine were also prepared. The plant at Toansa was designed to meet the stringent standards set by the Food and Drug Administration (FDA) of U. S. A.This plant has been approved by FDA and this will open up American and other newer markets for Eastern Medikit Ltd’s products At present Eastern Medikit Ltd have four plants for the manufacture of bulk drugs two at Mohali, one at Dewas (M. P) AND Another at Toansa near ROPAR. At present, Eastern Medikit Ltd is the second most Indian company engaged in the manufacturing of Pharmaceuticals, Bulk Drugs and Fine Chemicals. EASTERN MEDIKIT LTD’s vast range of highly pure laboratory reagent and chemicals enjoy a place of pride in the market.IT trends, has rebuilt As a step towards leveraging information for value creation using its information backbone around an ERP application, along the focus on reengineering several business processes aroun d the internet and has putting place business solutions that challenge existing ways of doing Business. The undying spirit of the company’s human assets and their intensive competitive and entrepreneurial energy has played a great part in transforming the company into a multicultural and multiracial team.Today, Eastern Medikit Ltd is the largest exporter accounting for 12% of the industry exports pharmaceutical substance and dosages forms to over 50 countries with the internationals sales comprising of 45% of the total turnover. VISION: GARUDA During the year 2002, the company has evolved a 10-year vision till 2012, for sustaining significant growth consistent with its mission to be an international research based Pharmaceutical Company, under the rubric ‘Vision Garuda’, with increasing emphasis on Novel Drug Delivery Systems Research (DDR).In licensing and out licensing, relationship with other important pharmaceutical entities, expansion of manufacturing facili ties both in India and strategic overseas locations, revamping of organizational structures to cater to the wider and more dispersed span of operations, and streamlining and standardizing the business processes through out the global organization, are other areas that receive focus and attention of management on priority. Mission â€Å"To become a Research based International pharmaceutical company† Vision-2012 Achieve significant business inProprietary prescription products By 2012 With a strong presence in developed markets Aspirations-2012 Aspire to be a$5 billion company Become a Top 5 global generics player Significant income from Proprietary products BOARD OF DIRECTORS At the helm entire operations is the experience and able direction of the people who make it all happen. Eastern Medikit Ltd acknowledges their inspiring stewardship and indefatigable work. * Mr. Tejendra Khanna(Chairman) * Mr. D. S. Brar (CEO $ Managing Director) * Mr. V. K. Kaul (Whole Time Director) * Dr.Brian Tempest (Whole Time Director) * Mr. Surendera Daulet Singh * Mr. Harpal Singh * Mr J. W. Balani * Mr. N. Kampani * Mr. V. Bharat Ram * Mr. Vivek Mehra Mr. Tejendra Khanna Mr. Tejendra Khanna was elected Chairman at a meeting of the Board of Directors of Eastern Medikit Ltd Laboratories Limited held at New Delhi, on July 5, 1999. Mr. Khanna, former Commerce Secretary to the Government of India, and a former Lieutenant Governor of Delhi is widely regarded as an expert in International Trade and Public Administration. Mr. D. S. BrarHe was instrumental in developing the Pharmaceutical exports business of the company in early 80’s, which later became synonymous with major growth and expansion of company’s portfolio. In addition to the International business, he looked after the Animal Healthcare & OTC businesses of the company. In 1986, he took over the Pharma business in India along with Chemical Manufacturing Operations. In early 90’s he led the companyâ⠂¬â„¢s expansion into overseas markets creating joint ventures, affiliates and subsidiaries in major countries like China, Russia, U. K. , South Africa and the USA.In 1996, he took over as the President of the company. Mr. V. K. Kaul Graduated in 1964 (B. Sc. Hons, Physics) from Ramjas College, University of Delhi, Mr. V. K Kaul joined the Institute of Chartered Accountants of India F. C. A. He is recognised in the industry for his vast experience and variegated knowledge. Dr Brian W. Tempest Dr Tempest joined Eastern Medikit Ltd as Regional Director- Europe, CIS & Africa in 1995 and subsequently took charge of Eastern Medikit Ltd’s worldwide pharmaceuticals business as President-Pharmaceuticals in the year 2000. In July 2001 he was appointed on the Board of Directors of Eastern Medikit Ltd.Dr. Tempest, 54, has worked in the Pharmaceutical Industry for 28 years, bringing in a wealth of global pharmaceutical experience and expertise. He has worked with leading multi-national c ompanies across several international markets including USA, Japan, Europe, China and other countries in Africa and Asia-Pacific. His unique combination of experience with both research-based and generic companies will be an asset in driving the company's growth in times ahead. Dr. Tempest is a Bachelor of Science with Honors from Aston University, specializing in Chemistry.He followed it up with a PhD in Polymer Chemistry from Lancaster University. Mr. Malvinder Mohan Singh Mr. Malvinder Mohan Singh is an Honors Graduate in Economics from Delhi University followed by a Masters Degree in Business Administration from Duke University, USA. He started his career with the American Express Bank and joined Eastern Medikit Ltd in May 1998. After holding several positions in the Company, has been appointed as â€Å"President Pharmaceuticals and Whole-time Director†, Eastern Medikit Ltd Laboratories Limited effective January 1, 2004OPERATING JOINT VENTURES AND SUBSIDIARIES BRAZIL:East ern Medikit Ltd S. P. Medicamentos Ltd. CHINA:Eastern Medikit Ltd (Guangzhou China) Ltd. EGYPT:Eastern Medikit Ltd Egypt Ltd. GERMANY: Basics Gmb H. HONG KONG:Eastern Medikit Ltd (Hong Kong) Ltd. INDIA:Rexcel pharmaceuticals Ltd. , Solus pharmaceuticals Ltd. , Vidyut Travel Services ltd. IRELAND:Eastern Medikit Ltd Ireland Ltd. MALAYSIA:Eastern Medikit Ltd (Malaysia) Sdn. Bhd. NETHERLANDS:Eastern Medikit Ltd Pharmaceuticals B. V. NIGERIA:Eastern Medikit Ltd Nigeria Ltd. PANAMA:Eastern Medikit Ltd Panama SA.POLAND:Eastern Medikit Ltd Poland Sp. Zo. SOUTH AFRICA:Eastern Medikit Ltd (SA) (Pty. ) Ltd. THAILAND:Unichem pharmaceuticals LTD. , Unichem Distributors Ltd. Part, Eastern Medikit Ltd Unichem CO. Ltd. U. K:Eastern Medikit Ltd (UK) Ltd USA: Eastern Medikit Ltd pharmaceuticals Inc. Ohm Laboratories Inc. , Eastern Medikit Ltd Schein Pharma, LLC VIETNAM: Eastern Medikit Ltd Vietnam Company Ltd. ALLIED BUSINESSES Eastern Medikit Ltd Animal Health The Animal Health division saw an enco uraging growth despite the prevailing poor market conditions.The division grew at twice the growth rate recorded in the industry. On the basis of having a vast dome satiated animal population, the livestock, poultry business and pets business are among the fastest growing sectors in India. A vast infrastructure of veterinary colleges, agricultural institutes, technologists and researchers are helping farmers to source healthy, cost effective products. In conjunction with the present scenario, the AHC division of Eastern Medikit Ltd Laboratories Limited has introduced several latest generation products. Eastern Medikit Ltd Fine Chemicals Limited (RFCL)The division ranked 4th in the industry and captured 11% market share. RANKEM is established as a powerful brand, RFCL's brand for its range of Reagents is now synonymous with excellence in reagents and fine chemicals in the country. The focus of business remains on developing extensive customer relations; enhancing service levels and e nriching the product mix with the help of a qualified and competent marketing and sales team Diagnostics The diagnostics division has aggressively focused on market expansion activities based on strategy of reliability, quality products and efficient service.Introduction of products in ‘Point of Care’ markets has expanded market presence and over the next 1 – 2 years this segment will see considerable expansion in line with world trends. The Dade Behring segment has increased its installation base by 60% in leading hospitals and laboratories. Plans are afoot for the introduction of more parameters for the ‘Point of Care’ market and the launch of Special Chemistries, a range of drug assays, plus an entry into automated microbiology in both the Base and Dade Behring business areas. The company has also witnessed significant milestones in the area of Novel Drug Delivery Systems (NDDS).The company has entered into strategic business arrangements with com panies such as Bayer AG, Glaxo-Wellcome, Eli-Lilly etc. for production and co-marketing operations. Many innovative developments have been taking place in recent times. The company’s research team is capable of developing one NDDS product every 12 to 18 months. Also, two new products: Roletra-D and Altiva-D, will soon be launched in India. In order to expand and promote global growth, the company opened several new markets during the year, notably in Brazil, where 25 filings were undertaken in a span of 2-3 months.The company has planned to build and protect intellectual property with the help of IPC, which addresses all matters pertaining to patents. CQA supervises the implementation of standard operating procedures (SOP) and ensures compliance to corporate quality assurance policy in all technological operations of the organization. The company is committed to invest 6% of the sales in R and D by 2003, of which 7% of the expenditure will be earmarked for research on New Dru g Discovery and Novel Drug Delivery Systems.There will be continuous emphasis on augmenting R and D performance and productivity with advanced scientific and technological tools. VALUES OF EASTERN MEDIKIT LTD LABORATORIES LIMITED 1. Achieving customer satisfaction is fundamental to their business. 2. Practice dignity and equity in relationships and provide opportunities for people to realize their full potential. 3. Ensure profitable growth and enhance wealth of shareholders. 4. Foster mutually beneficial relationships with all their business partners. 5. Manage their operations with concern for safety and environment. 6.Be a responsible corporate citizen. OBJECTIVES OF EASTERN MEDIKIT LTD LABORATORIES LTD. 1. To be a leader in the Pharmaceutical industry. 2. To be a profitable company with a steady growth in earnings. 3. To set an example as a socially responsible company. 4. To diversify in health care related areas. 5. To strive for excellence and continuous improvement in all sp heres. 6. To improve the quality of life of people by providing better services and quality products. Environment, Health and Safety [EHS] Caring for the Environment is a core corporate value and as a part of this commitment.The Company enunciated its EHS policy in 1993. The Company’s EHS policy provides for the creation of a safe and healthy workplace and a clean environment for employees and the community. It aims at higher international standards in plant design, equipment selection, maintenance and operations. The policy seeks to manufacture products safely and in an environmentally responsible manner. The implementation of the EHS Policy is ensured by institutionalizing a robust EHS Management system, adequately supported by well defined organizational structure.As a part of EHS processes at the corporate level, besides laying down guidelines on systems, policy and training, the corporate EHS office monitors compliance, maintains and disseminates information on laws and regulations. EHS performance review meetings are held on regular basis to monitor the progress against agreed EHS improvement plans. Close cooperation between all units and individuals is the key to maintaining high standards of environment protection and safety in all the plants.The key processes at location level comprise of regular safety surveillance, inspections & audits, Permit to work system for operational / maintenance safety, Fire prevention & protection activities, operation of the ETP/Incinerator, disposal activities related to hazardous wastes, regular monitoring of the environment internally and also through approved laboratories. Monthly reports address EHS initiatives, compliance & various records under the statutory requirement, training of employees including contract employees on EHS awareness, interaction with the residential associations/nearby community etc. celebration of National safety day, fire day, Environment day etc. for EHS awareness among employees. Th e manufacturing facilities for bulk drugs and dosage forms comply with the stringent requirements of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) and are approved by International health and regulatory Agencies like FDA – USA, MCA – UK, WHO etc. These practices and approvals ensure that an effective framework is always in place, not only for manufacture of high quality products, but also for effective use of resources and reduction of wastes as well as high safety & hygiene standards.Eastern Medikit Ltd has made significant improvements in process safety of the existing manufacturing facilities by providing extensive instrumented safety protection systems. The intended safety features are incorporated in the basic design of the new projects. Investments have been made on process improvements as well as effluent treatment plant up-gradation using the latest membrane based technology, multi-effect thermal evaporation system and state-of-the-art Incinerator. These investments have helped to reduce discharges of contaminants into the environment.With the facilities installed at Toansa for recycling of the treated effluent, the site has achieved the status of â€Å"zero discharge site†. The Company also engages with the concerned authorities and industry in devising responsible laws, regulations and standards and thus making safety, occupational health & environmental information and expertise available to its employees and the community at large. Eastern Medikit Ltd has made EHS concerns and practices a necessary factor in appraising its employee performance.The Company also accords a very high priority to hygiene monitoring at work place and health assessment of all employees at site. The plant and processes are continuously upgraded to improve hygiene and health standards. Necessary training is imparted to the employees to enhance their awareness towards health related matters. Safety knowledge of the employees is c onstantly updated through various external and in-house training programs, including special training programs by overseas experts & consultants.Moving up the value chain, the company identified Consumer Healthcare as its new business area in the year 2001. Eastern Medikit Ltd Global Consumer Healthcare (RGCH) was launched in October 2002 with a portfolio of 4 switch brands: Revital, Pepfiz, Gesdyp & Garlic Pearls. Since these brands were already popular amongst consumers and represented the leading common ailment categories like VMS (Vitamins & Minerals Supplement), this portfolio was carefully created for the introduction of RGCH to the Indian market.Subsequently in 2004, RGCH launched its first herbal range of products through New Age Herbals (NAH) with products offering remedy in categories of Cough & Cold (Olesan Oil & Cough Syrups) and Appetite Stimulant (Eat Ease). VARIOUS DIVISIONS OF EASTERN MEDIKIT LTD LABORATORIES LTD. 1. Chemical Division 2. Diagnostic Division 3. Stan c are Division 4. Curradia Division 5. International Division 6. Pharmaceutical Division 7. Technical Division 8. Corporate Division 9. Animal Health Care Division DIVISIONS IN VARIOUS GEOGRAPHICAL AREAS 1. India and Middle East 2. Europe, CIS and Africa 3.Asia Pacific and Latin America 4. North America JOINT VENTURE OF THE COMPANY. 2000Eastern Medikit Ltd files IND Application for Asthma Molecule- RBx4638, after successful completion of pre-clinical studies. Eastern Medikit Ltd acquires Bayer’s Generics business (trading under the Name of Basics) in Germany. Eastern Medikit Ltd forays into Brazil, the largest pharmaceutical market in South America and achieves global sales of U. S. $ 2. 5 million in this market. 2001Eastern Medikit Ltd took a significant step forward in Vietnam by initiating the Setting up of a new manufacturing facility with an investment of U.S. $ 10 million. Eastern Medikit Ltd achieved a turnover of U. S. $ 502 million for the year 2002 and moved closer to achieving a target of 1 billion dollar by 2004. 2002Receives approval from FDA to market Midazolam Hydrochloride Syrup 2 Mg base/ ml. Eastern Medikit Ltd receives and approval from FDA to manufacture and market Cefpodoxime Proxetil for Oral Suspension, Lisinopril + Hydrochlorothiazide Tablets Us, Terazosin Hydrochloride Capsules and Amoxcillin Oral suspension USP. Heralding the company’s entry into the Indian OTC market. 003Eastern Medikit Ltd received the economic times award for corporate excellence-for the company for year. Eastern Medikit Ltd signed an agreement toacquire RPG(aventis) SA along with its fully owned subsidiary,OPIH SARL,in france 2004 Eastern Medikit Ltd launched its first range of herbal projects. 2005 Acquisition of additional stake in Eastern Medikit Ltd Farmaceutica Ltda. , Brazil Eastern Medikit Ltd announced the acquisition of Be-Tabs Pharmaceuticals (Pty) Limited 2008Acquired by the Japanese giant, the $9. 62 billion Daiichi Sankyo, ranked No. in Ja pan BRIEF INTRO OF EASTERN MEDIKIT LTD PLANTS IN INDIA In the chemical division, various bulk drugs are manufactured. The chemical division had three units in Punjab. One is located at Toansa, two are located at Mohali and one unit is located at Dewas near Indore in Madhya Pradesh, where Ciprofloxacine is manufactured. In the plant of the chemical division, various drugs like Antibiotics, Anti-malarial, Antibacterial and Anti-ulcer are manufactured. One of the older plants of Eastern Medikit Ltd was closed after the accident in June 2003. he second one is still working The 1991, the Toansa plant started functioning in 1992 and the Dewas plant started functioning in 1999. Various plant heads independently manage all these plants. In each unit, separate facilities with respect to the manufacture of drugs, along with their manufacturing areas have been provided. This is required to reduce the chances of any cross contamination under the drug laws and to comply with good manufacturing p ractices. At Mohali plant, separate blocks have been provided for the preparation of each drug .The Toansa, Mohali and Dewas plants are planned in such a way that their system, facilities, manufacturing practices and standards meet the requirements of FDA. Mohali Plant also mainly in the manufacturing of Active Pharmaceutical Ingredients (API). The Plant is divided into two plant areas A8 and A9 THE VARIOUS DEPARTMENTS Human Resource Department The basic function of the human resource department in the modern corporate world is knowledge management. The HR department strives to maintain cohesiveness among employees. It also ensures interdepartmental cooperation in achieving targets.The appraisal system is also taken care by this department. The HR department delves deep into the employee’s psyche to analyze the positives and negatives of each employee, so that a proper system of delegation and / or empowerment can be evolved. Finance Department The finance department takes ca re of the regular financial needs of the company it ensures proper allocation of funds and takes care of the working capital requirements. It verifies capital raised by different departments and sends them for approval to the higher authorities. Stores DepartmentThe function of this department is to provide adequate and proper storage and preservation of various items to meet the demand of various other departments by proper issues and maintaining accounts of consumption. It also keeps a track of stock accumulation and abnormal consumption. Erection and Fabrication Department As the name suggests, this department identifies new projects and helps in erecting them. This department also undertakes major modifications of equipment. ERP Department ERP department helps to integrate the entire enterprise starting from the supplier to the customer, covering financial and human resources.This will enable the enterprise to increase productivity by reducing costs. It also ensures a single sol ution to the information needs of the whole organization. Production Department As a part of their on going commitment to produce hi-tech quality drugs and pharmaceuticals that take care of the specific needs of markets around the world, Eastern Medikit Ltd Laboratories Limited has increased the investment in the production department. It is the most important department of the company and has the following objectives: 1. Improving volume of production. 2.Reducing rejection rate. 3. Maintaining rework rate. Engineering Department This department undertakes building, construction and maintenance. Maintaining service facilities such as water, gas, heating, ventilation, air conditioning, painting and plumbing are some of the other areas dealt by this department. This department also helps in maintaining electrical equipments such as generators, transformers, telephone system and electrical installation. Purchase Department The purchase department provides material to the factory withou t which the wheels of machines cannot move.The various functions performed by this department include: Securing good vendor performance, including prompt deliveries of supplies of acceptable qualities. 1. To develop satisfactory sources of supply and maintaining good relationships with the suppliers. 2. To pay reasonably low prices. Quality Control/Quality Assurance Department The purpose of QC & QA departments is to ensure that the desired quality standard is achieved. It also ensures that the processing or fabrication of material conforms to the specific characteristics selected, to assure that the resulting product will in fact perform its intended function. PRODUCT REVIEWEastern Medikit Ltd’s therapeutic width covers five of the top six categories including Anti-infective, Gastrointestinal, Nutritionals, Cardiovascular, Central Nervous System, Respiratory, Dermatological and others. While anti-infective contribute 56% of the total sales, Eastern Medikit Ltd’s other brands like Simvotin and Storvas in the cardiovascular segment, Serlift in CNS and Revital and Riconia in Nutritionals, are on their way to success in multiple markets. During Jan – Dec 2000, amongst the top products of Eastern Medikit Ltd, Sporidex (Cephalexin) was the Number 1 brand, closely followed by Cifran (Ciprofloxacin).Anti – Infectives Anti- infective has been the main driver of Eastern Medikit Ltd’s sales. The important brands in this category are Cifran (Ciprofloxacin), Sporidex (Ciphalexin), Enhancin (Amoxyclav), Crixan (Clarithromycin), Vercef (Cefaclor), Oframax (Ceftriaxone), Cepodem (Cefpodoxime Proxetil), Zanocin (Ofloxacin), Ceroxim (Cefuroxime Axetil), and Loxof (Levofloxacin). Cifran (Ciprofloxacin) is the key brand in the anti- infective portfolio, with estimated sales of US $ 32 Mn, currently being marketed in 15 countries. Development of Ciprofloxacin once a day has been an important landmark achieved by Eastern Medikit Ltd.The product h as been licensed to Bayer. Cifran continues to be a dominant player in the quinolones market in India, China and Russia. Sporidex is another leading brand in Eastern Medikit Ltd’s product portfolio with worldwide annual sales of US $ 35 Mn. It is available in eight different dosage forms including capsules, dry powder for suspension, redimix, dispersible tablets, paediatric drops, soft gelatin capsules, sachet and advanced formulation for twice-daily administration. It is currently marketed in 15 countries. In India, Sporidex is the leading brand with a market share of 36% of the Cephalexin segment.Keflor is available in seven different dosage forms and is the third-largest selling brand for Eastern Medikit Ltd worldwide. The dosage forms list includes capsules, dry syrup, modified release tablets, dispersible tablets, drops and redimix. Enhancin is expected to be the leading product in Eastern Medikit Ltd’s product portfolio with estimated sales of US $ 45 Mn by the y ear 2005. The product will be rolled out to about 20 important markets during this period. Zanocin, with approximate sales of US $ 10 Mn, is the seventh-largest contributor to Eastern Medikit Ltd’s total sales.Cepodem is currently available in three different countries outside India, and will be rolled out to 13 different countries in the near future. Cardiovasculars Cardiovascular is projected to be the second-best category for Eastern Medikit Ltd. Statins have been the key drivers for this segment. The sale of Simvastatin has grown substantially in the past few years, a trend that is likely to continue in the future. In India, Simvotin (Simvastatin) is the market leader in the cholesterol reducer segment. Another leading brand in this category is Storvas (Atorvastatin).Storvas has been one of the fastest-ever to enter the top-300 brands list of the Indian pharma industry. Other global cardiovascular brands are Covance (Losartan) and Caslot (Carvedilol). Central Nervous Syst em The Central Nervous Segment is one of the important focus areas identified by Eastern Medikit Ltd, with Serlift being the key brand. In India, Serlift is number 1 amongst Sertraline brands. New product introductions will be drivers of growth in this category. Gastrointestinal Currently, gastrointestinal drugs are the second-largest category for Eastern Medikit Ltd.The key brands in this category include Histac and Romesac. The current annual sales of Ranitidine are estimated to be around US $ 16 Mn and the product is marketed in more than 20 countries. Rheumatologicals The first generation Cox-2 inhibitors principally drive worldwide growth in rheumatology. This category is estimated to grow exponentially for Eastern Medikit Ltd, with brands like Celecoxib. This year, Rofibax (Rofecoxib) introduced in India, has established itself as a leader in the Cox-2 inhibitor category and has overtaken all Celecoxib brands. It has been identified as a key Global brand for the future.Nutrito nals Nutritionals have been a major contributor to Eastern Medikit Ltd’s sales. Two of the important products in this category are Revital and Riconia. With annual sales estimated at about US $ 10 Mn, Revital contributes a significant share of total sales. It is a leading brand in India and has done exceedingly well in some parts of the world as an OTC product. Dermatologicals The dermatology category is mainly driven by India region and is likely to show a good growth pattern in the future. Some of the key brands doing well in this segment are Mobizox, Silverex, Moisturex, etc.INTRODUCTION TO CAPITAL STRUCTURE THEORY AND ANALYSIS This is a Report on the ‘Capital Structure and Capital Expenditure of Eastern Medikit Ltd Laboratories Ltd. ’. The purpose and scope of the project can be listed as: * Understanding the organizational structure and functioning of Eastern Medikit Ltd Laboratories Ltd. * Analysing and comparing the financial health of the firms in the Ind ian Pharma Industry. * Identifying and analysing the capital structure of Eastern Medikit Ltd. * Conducting a Review of the Capital Expenditure done at Eastern Medikit Ltd Laboratories Ltd. Identifying loopholes in the functioning and in the area of study and recommending the suggestions for the same. Following are the limitations of the study: * Balance sheets of only 3 years have been studied but the company is in operation for so many years. * Only specific tools (i. e. ratio analysis) have been used for data analysis, while so many other tools are also there. * Organizational rules & regulations. * Availability of data. Financial figures for 2008 of Eastern Medikit Ltd were not available. * Limitations of the financial tools used. MethodologyThe methodology adopted for the study was as follows: * Familiarization, examination and evaluation of the procedures relating to capital structure and capital expenditure. * Collection of relevant data form company records and cross checkin g of this data. * Calculations of financial ratios, parameter and norms, as also their financial implications. Broadly the data were collected for the report on the project work has been through the primary and secondary sources. The primary data is collected by various approaches so as to give a precise, accurate, realistic and relevant data.The main goal in the mind while gathering primary data was investigation and observation. The ends were thus achieved by a direct approach and personal observation from the officials of the company. The other staff members and the employees were interviewed for the sake of maintaining reasonable standard of accuracy. The secondary data as it has always been important for the completion of any report provides a reliable, suitable equate and specific knowledge. The annual reports, the fixed asset register and the Capex register provided the knowledge and information regarding the relevant subjects.The valuable cooperation and continued support ex tended by all associated personnels, head of the department, division and staff members contributed a lot to fulfil the requirement in the collection of data in order to present a complete report on the project work. Capital Structure: Theory and Analysis Capital Structure Financing decisions involve raising funds for the firm. It is concerned with formulation and designing of capital structure or leverage. The most crucial decision of any company is involved in the formulation of its appropriate capital structure.The best design or structure of the capital of a company helps the management to achieve its ultimate objectives of minimising overall cost of capital, maximising profitability and also maximising the value of the firm. The capital structure decision of a firm is concerned with the determination of debt equity composition. Capital structure ordinarily implies the proportion of debt and equity in the total capital of a company. The term capital may be defined as the long â €“ term funds of the firm. Capital is the aggregation of the items appearing on the left hand side of the balance sheet minus current liabilities.In other words capital may be expressed as follows: Capital = Total Assets – Current Liabilities. Further, capital of a company may broadly be categorised into equity and debt. The total capital structure of a firm is represented in the following figure: Established companies generally have track record of their profit earning capacity, which helps them to create their creditworthiness. The lenders feel safe to invest their funds in such companies. Thus, there is ample scope for this type of companies to collect debt. But a company cannot freely i. e. without having any limit.The company must have to chalk out a plan to collect a debt in such a way that the acceptance of debt becomes beneficial for the company in terms of increase in EPS, profitability and value of the firm. If the cost of capital is greater than the return, it will have an adverse effect on company’s profitability, value of the firm and its EPS. Similarly, if company is unable to repay the debt within the scheduled period it will affect the goodwill of the company in the credit market and consequently may create problems in future for collecting further debt.Other factors remaining constant, the company should select its appropriate capital structure with due consideration. Capital structure involves a choice between risk and expected return. The optimal capital structure strikes the balance between these risks and returns and thus examines the price of the stock. Significant variations with regard to capital structure can easily be noticed among industries and firms within the same industry. So it is difficult to generate the model capital structure for all business undertakings.The following is an attempt to consolidate the literature on various methods to suggested by researchers in arriving at optimal capital structure. Notatio ns used: * V = value of firm * FCF = free cash flow * WACC = weighted average cost of capital * rs and rd are costs of stock and debt * re and wd are percentages of the firm that are financed with stock and debt. Operating and Financial Leverages The term leverage refers to the ability of a firm in employing long – term funds having a fixed cost, to enhance returns to the owners. In other words everage is the employment of fixed assets or funds for which a firm has to meet fixed costs or fixed rate of interest obligation irrespective of the level of activities attained or the level of operating profit earned. Higher the leverage, higher the profits and vice – versa. But a higher leverage obviously implies higher outside borrowings and hence riskier if the business activity of the firm suddenly takes a dip. But a low leverage does not necessarily indicate prudent financial management, as the firm might be incurring an opportunity cost for not having borrowed funds at a fixed cost to earn higher profits.Operating Leverage Operating leverage is concerned with the operation of any firm. The cost structure of any firm gives rise to operating leverage because of the existence of fixed nature of costs. This leverage relates to the sales and profit variations. Operating Leverage =| Contribution| | EBIT| Contribution = Sales – Variable Costs EBIT = Earnings Before Interest and Taxes. Disadvantages of Operating Leverages * The reliability of operating ratios rests to a large extent on the correctness of the fixed costs identified with a product. Faulty apportionment would distort the usefulness of the ratio. The published accounts does not give details of the fixed cost incurred and the contribution from each product and for an outsider it is difficult to calculate the firm’s operating leverage. Firm’s cost structure and nature of the firm’s business affects operating leverage. A degree change in sales volume results in more tha n proportionate change (+/-) in operating (or loss) can be observed by use of operating leverage. Financial Leverage This ratio indicates the effects on earnings by rise of fixed cost funds. It refers to use the use of debt in the capital structure.Financial leverage arises when a firm deploys debt funds with fixed charge. The ratio is calculated with the following: * Earnings before interest and tax / Earnings after interest – The higher the ratio, the lower the cushion for paying interest on borrowings. A low ratio indicates a low interest outflow and consequently lower borrowings. A high ratio is risky and constitutes a strain on profits. This ratio is considered along with the operating ratio, gives a fairly and accurate idea about the firm’s earnings, its fixed costs and the interest expenses on long term borrowings. Earnings per Share – Higher financial leverage leads to higher EBIT resulting in higher EPS, if other things remain constant. Financial levera ge affects the variability and expected level of EPS. The more debt the firm employs the higher its financial leverage. Financial leverage generally raises expected EPS, but it also increases the riskiness of securities as the debt / asset ratio rises. Financial Leverage =| EBIT| | EBT| EBIT – Ea

HR Training Class

Organizations are continuously seeking to improve quality in which there is more focus on their customer service and relations. In most organizations the customer service skills contribute to the success of the organization. Individuals with good people skills are the foundation to excellent customer service. The skills associated with good customer service are problem solving, team work, leadership selection is not an effective way to improve productivity in situations where only a few applicants compete for a large number of openings, or a business involves only easily learned tasks (Brown, 1996).Employees have many options to improving their performance In the event an organization encounters these situations, selection techniques would not be used but training would be used. In any organization, when employees have interactions with customers it represents the organization. The perception held by the customers experience will influence how they will perceive the organization and its products. When determining the training needs of organizations employees and filling positions are important factors in the HR management processes.Having the right number of people with the right training in the right jobs to meet its sales goals for the new product is essential in a viable organization (Kusluvan, 2003). A job analysis needs to be completed to know the skills needed for each position. The job description will lay out the skills and abilities of an individual needed to fill a job will come from the job analysis. The needs assessment role is to give answers to such commonly asked questions such as the when, who, and why.Conducting needs assessment protects the assets of an organization and facilitates conservation and proper utilization of resources set aside for training. A needs assessment helps to know whether training is the ideal solution to a performance deficiency (Barbazette, 2006). If training does not help resolve a deficiency in skills and knowledge, t here would be no need for the training. Organizations should know the reason training to avoid wasting resources in training materials. Needs Assessment PurposeAltschuld and White (2010) point out training needs assessment serves several multiple purposes only if proper implementation takes place. The needs of the organization is the most important when it comes to the training offered. Serving the business needs with training adds value only when it is  needed. Lastly, it will help correct the issues that the clients may present. The clients know what they want but do not know the way to correct issues concerning human performance. A needs assessment can communicate distinctive information given by the client, also give other reason on the clients original feeling.The other reason for the assessment is to match up with the employee’s performance needs ultimately meeting the needs of the organization. A major role of the assessment is to gather the information that will bac k the design of the training, which best fits the needs of the employee’s job description. Also, it results in recommendations regarding non-training issues that are affecting the achievement of the desired organization and employee performance goals (Barbazette, 2006). It is equally as important for the individual assessor to know the issues and give suggestions as to how these issues could be addressed. In addition, training needs assessment helps protect the continuance of the training functions in an organization.During hard times the risk will not be so high if the training provided adds value to the organization. In the process of a needs assessment one should consider the needs of the business, employee performance, and individual learning. The evaluation methods consist of different factors such as organization needs, learner reaction, job performances and learning. The goal in training is to be able to identify positive changes in each of the four needs assessment pr e-measures when post-measured during evaluation (Lenan & Bailey, 2006). The evaluation measurement can cause the organization to begin a new needs assessment. A needs assessment uncovers the existing performance deficiencies. The assessment will address the following questions: Need of training?Organizations need to compare the deficiency to the business needs and confirm that the positive outcome of training employees outweighs the problems inherent in performance deficiency (Tobey, 2005). In order to answer this question, one will have to complete an alternative analysis along with a feasibility analysis. Individual training?Individuals that can provide a solution to the deficiency should be involved in the training. The targeted population should be analyzed to acquire the knowledge of their deficiency. The analysis will also help design the  training program needed and that would be of interest. Unstable Performance ResolvedThe best way to solve performance issues is by offeri ng training or if training is not feasible offer was to solve the issues. A performance analysis will identify the deficiency of skills; this can be solved by training. Best Performance Ways?To achieve the best results there is a better way to accomplish the task. Job performance standards such as Standard Operating Procedures (SOP) should be set by the organization (Tobey, 1987). Government regulations should also be considered when completing the task in a required manner. Conduct task analysis to identify the best way to perform. Training Timing?Organizations have to consider the best time to complete the training due to the holiday schedules and business cycles will impact the employee attendance.Improvement of the organizations performance is done through the performance and commitment of the employees as well as training. Training will aid employees in their current roles and help develop them for possible future added responsibilities. Some of the purposes of training are to update employee skills, preparation for promotion, and success in management while satisfying the employee needs. Some organizations provide apprentice training.The implementation of a training program being successful depends on more than the organizations ability to identify the needs. The success depends on the ability to obtain information to design a training program to fit the need. Some experts think that the design of the training programs should be focused on objectives of the instructional training’s willingness of employees, instructor’s characteristics and principles of learning. There are many methods of training employees, these methods consist of presentations, role play, on the job training, case study, online web base seminars and simulations.The method of training chosen is online web- based training because it is very convenient to use. If ones company is not  already using it, then there should be plans to implement online training as a part of th e overall plan for education. Web-based training has several advantages. †¢Provides employees access to training materials twenty four hours a day so, they can learn and complete on their own schedule †¢Management can track employees progress†¢Expenses are cut due to not having to provide instructors, venue or materials †¢It enables staff members from various geographical settings to take the training at their convenience without the time or expense of traveling. Since the introduction of the internet, organizations now have virtual online training. This is a way that the company can offer training on various subjects in an online environment. Some organizations offer certificate programs for the completion of the courses employees complete. Ways to motivate employeesThe most indisputable way to motivate employees into attending a training session is to make it a requirement to attend training on scheduled work hours. There are ways to motivate employees that are not interested in attending training sessions are as follows (Tobey, 2005; Rossett, 1987).Provide incentivesThe most common incentives for employees to attend training will include opportunities for promotion, college credits, certificates and monetary compensation. Relate the training to an employee’s immediate jobEmployees are more willing to attend training when the material covered will be directly related to their immediate job performance. Employees would be more motivated to attend a training session on a computer program that the organization will be using in two months than a training session on â€Å"Future Trends on Office Automation† (Rosset, 1987). Therefore, training should be provided before the implementation of the product instead of with the thought of we may use it. Make the training interestingEmployees are more interested and willing to go to training if the session are interesting and they gain useful information associated with their position. I ncrease employee buy-in in the trainingIf the employee has a say in the information covered and the type of training given they will be more likely to attend these sessions. Provide the food.The organization provides lunch during the training session for the employees as the presentation is carried out. This would be the highest possibility that the employees would attend this training. Reduce the stress of attending the trainingOften times, employees are willing to attend training but their schedule constraints keep them from taking the time away from their schedules. The organization can assist employees with attending training by reducing their workload or giving assistance with workload. Customer feedback is significant to respond to customer needs and issues to ensure satisfaction of the Company’s products and services (Brown, 1996). Feedback in training is important in helping make improvements for future training sessions. Sample of survey used to collect feedback.1. O verall how would you rate the training class? ExcellentGoodFairPoor*2. Please rate the following aspects of the training classExcellentGoodFairPoorn/a Did your trainer actively ask questionsDid your trainer have a professional demeanorPlease rate the qualifications of the instructor3. Based on your experience at this training class, how likely are you to attend future training class with this instructor? Very likelySomewhat likelyNot likely4. What did you learn from the training?ExcellentGoodFairPoorn/a5. What do you think about the quality of training?ExcellentGoodFairPoorn/a6. Were the training materials enough?7.Suggest other methods of training8.What did you learn from the training?In conclusion, all organizations should place training employees on customer service at the top of their priorities. Customers will continue to come back when they receive good service and back service will drive customers away. Therefore all organizations need to continue to enhance the customer serv ice skills of their employees through customer service training.

Commerce Clause Meaning and Applications

Commerce Clause Meaning and Applications The Commerce Clause is a provision of the U.S. Constitution (Article 1, Section 8) that grants Congress the power â€Å"to regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes. This law gives the federal government the power to regulate interstate commerce, which it defines as the sale, purchase, or exchange of commodities or the transportation of people, money, or goods between different states.   Congress has historically cited the Commerce Clause as justification for laws and regulations controlling the activities of the states and their citizens. In some instances, these laws lead to controversy over the constitutional division between the powers of the federal government and rights of the states. Dormant Commerce Clause The courts have interpreted the Commerce Clause as not only an explicit grant of power to Congress, but also an implied ban against state laws that conflict with federal law- sometimes called the Dormant Commerce Clause. The Dormant Commerce Clause refers to the Commerce Clause’s implied prohibition against state laws that conflict with federal law by discriminating against or excessively burdening interstate commerce. This prohibition is primarily intended to prevent the states from enacting â€Å"protectionist† trade laws. What Is Commerce? Since the Constitution does not explicitly define â€Å"commerce,† the exact meaning is a source of legal debate. Some constitutional scholars contend that â€Å"commerce† refers only to trade or exchange. Others argue that it has a broader meaning, referring to all commercial and social interaction between residents of different states. These divergent interpretations create a controversial line between federal and state power. Interpretation of Commerce: 1824 to 1995 The first legal interpretation of the scope of the Commerce Clause came in 1824, when the Supreme Court decided the case of Gibbons v. Ogden. In one of the first major expansions of the powers of the federal government, the Court ruled that Congress could use the Commerce Clause to enact laws regulating both interstate and intrastate trade. In the 1905 case of Swift and Company v. United States, the Supreme Court refined its 1824 interpretation by ruling that Congress could apply the Commerce Clause in regulating the practices of local businesses- intrastate commerce- only if those local business practices were in some way a part of a â€Å"current† or stream of commerce that also involved the movement of goods between states. In the 1937 case of NLRB v. Jones Laughlin Steel Corp, the Court significantly broadened the reach of the Commerce Clause. Specifically, the Court held that any local business activity could be defined as â€Å"commerce† as long as it had or was likely to have a â€Å"substantial economic effect† on interstate commerce. Under this interpretation, for example, Congress gained the power to enact laws regulating local firearms dealers if any of the guns they sell are manufactured outside of their states. Over the next 58 years, not a single law based on the Commerce Clause was invalidated by the Supreme Court. Then, in 1995, the Court narrowed its interpretation of commerce with its ruling in the case of United States v. Lopez. In its decision, the Court struck down parts of the federal Gun-Free School Zones Act of 1990, finding that the act of possessing a firearm is not an economic activity. Current Interpretation: The Three-Part Test When deciding that a state law is a valid exercise of the state’s power to regulate interstate commerce under the implied prohibitions of the Commerce Clause, the Supreme Court now applies this three-part test: The law must in no way discriminate against or excessively interfere with interstate commerce.The commerce regulated by the state law must not be of a nature that requires regulation by the federal government.The federal government’s interest in regulating the commerce in question must not outweigh the interest of the state. To uphold a state law under the Commerce Clause, the Supreme Court must find that the law’s benefits outweigh its burdens on interstate commerce. In addition, the Court must find that in enacting the law, the state is not attempting to advance the economic interest of its own citizens over those of the citizens of other states. Current Applications in Law In its 2005 decision in the case of Gonzales v. Raich, the Court returned to a wider interpretation of the Commerce Clause when it upheld federal laws regulating the production of marijuana in states that had legalized marijuana possession. The Supreme Court’s most recent interpretation of the Commerce Clause came from the 2012 case of NFIB v. Sebelius, in which the Court upheld Congress’ power to enact the individual mandate provision of the Affordable Care Act requiring all uninsured individuals to secure health insurance or pay a tax penalty. In reaching its 5-4 decision, the Court found that while the mandate was a constitutional exercise of Congress’ power to tax, it was not a proper use of Congresss Commerce Clause or Necessary and Proper Clause powers. Sources †Commerce Clauseâ€Å" Legal Information Institute. Cornell Law School.â€Å"Commerce Clause Limitations on State Regulation.† University of Missouri-Kansas CityWilliams, Norman. Why Congress May Not Overrule the Dormant Commerce Clause. UCLA Law Review (2005). â€Å"Federal Courts Split on Constitutionality of Individual Mandate in Health Care Law.† Regulatory Review (2011).